We found that the suppressive activity of CD4+CD45RO+ memory T-cells on IL-1β secretion by monocytes was significantly reduced in untreated MS patients compared to healthy controls (p<0.05) (Fig 7a). This evidence concerns the gene IL1B and myeloid sarcoma.